New tricks for old dogmas: Optogenetic and designer receptor insights for Parkinson's disease

被引：24

作者：

Vazey, Elena M. ^{[1
]}

Aston-Jones, Gary ^{[1
]}

机构：

[1] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA

来源：

BRAIN RESEARCH | 2013年 / 1511卷

关键词：

Optogenetic; DREADD; Parkinson's disease; Basal ganglia; Non-motor; Norepinephrine; Dopamine; Striatum; PROTEIN-COUPLED RECEPTORS; TRANSGENIC MICE; LOCUS-COERULEUS; COGNITIVE IMPAIRMENT; NEURAL CIRCUITRY; GENE-THERAPY; ASTROCYTES; NEURONS; BRAIN; INHIBITION;

D O I：

10.1016/j.brainres.2013.01.021

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Optogenetics and novel designer receptors have revolutionized the way neuroscientists can interrogate neural circuits. These new tools are being rapidly applied to many facets of neuroscience including the study of Parkinson's disease circuitry and therapies. This review highlights how optogenetics and designer receptors can be applied in the study of Parkinsonian dysfunction to understand the mechanisms behind motor and non-motor symptoms. We discuss how these tools have recently advanced our understanding of basal ganglia function and outline how they can be applied in future to refine existing treatments and generate novel therapeutic strategies for Parkinson's disease. This article is part of a Special Issue entitled Optogenetics (7th BRES) (C) 2013 Elsevier B.V. All rights reserved.

引用

页码：153 / 163

页数：11

共 91 条

[51] AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial [J].

LeWitt, Peter A. ;

Rezai, Ali R. ;

Leehey, Maureen A. ;

Ojemann, Steven G. ;

Flaherty, Alice W. ;

Eskandar, Emad N. ;

Kostyk, Sandra K. ;

Thomas, Karen ;

Sarkar, Atom ;

Siddiqui, Mustafa S. ;

Tatter, Stephen B. ;

Schwalb, Jason M. ;

Poston, Kathleen L. ;

Henderson, Jaimie M. ;

Kurlan, Roger M. ;

Richard, Irene H. ;

Van Meter, Lori ;

Sapan, Christine V. ;

During, Matthew J. ;

Kaplitt, Michael G. ;

Feigin, Andrew .

LANCET NEUROLOGY, 2011, 10 (04) :309-319

[52] Optogenetic activation of LiGluR-expressing astrocytes evokes anion channel-mediated glutamate release [J].

Li, Dongdong ;

Herault, Karine ;

Isacoff, Ehud Y. ;

Oheim, Martin ;

Ropert, Nicole .

JOURNAL OF PHYSIOLOGY-LONDON, 2012, 590 (04) :855-873

[53] Transgenic expression of Cre recombinase from the tyrosine hydroxylase locus [J].

Lindeberg, J ;

Usoskin, D ;

Bengtsson, H ;

Gustafsson, A ;

Kylberg, A ;

Söderström, S ;

Ebendal, T .

GENESIS, 2004, 40 (02) :67-73

[54] A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing [J].

Madisen, Linda ;

Mao, Tianyi ;

Koch, Henner ;

Zhuo, Jia-min ;

Berenyi, Antal ;

Fujisawa, Shigeyoshi ;

Hsu, Yun-Wei A. ;

Garcia, Alfredo J., III ;

Gu, Xuan ;

Zanella, Sebastien ;

Kidney, Jolene ;

Gu, Hong ;

Mao, Yimei ;

Hooks, Bryan M. ;

Boyden, Edward S. ;

Buzsaki, Gyoergy ;

Ramirez, Jan Marino ;

Jones, Allan R. ;

Svoboda, Karel ;

Han, Xue ;

Turner, Eric E. ;

Zeng, Hongkui .

NATURE NEUROSCIENCE, 2012, 15 (05) :793-802

[55]

Mahler S.V., 2012, NEUROPSYCHOPHARMACOL, V38, pS198

[56] Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats [J].

Mallet, N ;

Ballion, B ;

Le Moine, C ;

Gonon, F .

JOURNAL OF NEUROSCIENCE, 2006, 26 (14) :3875-3884

[57] Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease [J].

McFarland, Krista ;

Price, Diana L. ;

Bonhaus, Douglas W. .

BEHAVIOURAL PHARMACOLOGY, 2011, 22 (07) :681-692

[58] Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis [J].

Meltzer, Herbert Y. ;

Mills, Roger ;

Revell, Stephen ;

Williams, Hilde ;

Johnson, Ann ;

Bahr, Daun ;

Friedman, Joseph H. .

NEUROPSYCHOPHARMACOLOGY, 2010, 35 (04) :881-892

[59]

Meyers R., 1940, ARCH NEURO PSYCHIATR, V44, P455

[60]

Nair S.G., 2012, BRAIN RES, V17

← 1 2 3 4 5 6 7 8 9 10 →